Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Important update regarding AGM

16 Apr 2020 13:00

RNS Number : 8053J
Indivior PLC
16 April 2020
 

Indivior PLC - Important update regarding AGM

 

On 13 March 2020, the Company published the notice convening its 2020 Annual General Meeting. Since its publication, the UK government has introduced measures to limit the impact of COVID-19, which includes social distancing measures and the prohibition of non-essential travel and public gatherings of more than two people (the 'Stay at Home measures').

 

The Board of Directors (the 'Board') of Indivior PLC have been monitoring the COVID-19 situation and have also taken account of the recent guidance issued by the Chartered Governance Institute regarding the impact of COVID-19 on AGMs. The introduction of the Stay at Home measures means that it will not be possible for shareholders to attend this year's Annual General Meeting ('AGM') in person.

 

Change of venue and arrangements

 

The AGM will no longer be held at the original venue and the meeting will now be held at the Company's registered office at 234 Bath Road, Slough, Berkshire, SL1 4EE. The date and time of the meeting, Thursday, 7 May at 3.00pm, is unchanged.

 

As a consequence of the Stay at Home measures, the arrangements for the AGM are as follows:

 

- attendance will be limited to essential personnel only to ensure that a quorum is present and to conduct the business of the AGM (attendance by these persons will be considered essential for work purposes);

- other shareholders will not be able to attend the AGM in person; and

- the format of the meeting will be restricted to the formal business of the AGM only.

 

Shareholders can submit questions to the Board in advance of the AGM by email to cosec@indivior.com. The Board will, where appropriate, answer shareholders' questions by publishing written responses on the Company's website at www.indivior.com.

 

The Board believes these measures are necessary and appropriate in light of the COVID-19 pandemic and, in particular, to protect the health and wellbeing of our employees, shareholders and the wider communities in which we operate.

 

Reminder to vote by proxy

 

The AGM is an important event in the Company's corporate calendar and provides an opportunity for shareholders to vote on important resolutions for the conduct of the business and affairs of the Company. Accordingly, the Board strongly encourages participation of all shareholders by:

1. Appointing the Chair of the AGM as their proxy.

2. Submitting a form of proxy as soon as possible and in any event by no later than 3.00pm (BST) on Tuesday, 5 May 2020 to ensure that their votes are counted. If a shareholder appoints a person other than the Chair of the AGM as their proxy, that other proxy will not be able to attend the AGM.

3. Re-submitting a new form of proxy to appoint the Chair of the AGM to replace any form already submitted which appoints a person other than the Chair of the AGM as their proxy.

A form of proxy may be submitted electronically by following the links provided at www.investorcentre.co.uk/eproxy or by returning the form to the Company's registrar, Computershare. Details of how to submit proxies are set out on page 9 of the Notice of AGM that was circulated to shareholders on 13 March 2020. Proxy instructions must be received no later than 3.00pm (BST) on Tuesday, 5 May 2020 or not less than 48 hours before the time of the holding of any adjourned AGM. For shares held through CREST, proxy appointments may be submitted via the CREST proxy voting system.

 

The Board will continue to monitor the situation and may, if necessary, make further changes to the arrangements for the AGM. Shareholders should therefore continue to monitor the Company's website and RNS announcements.

 

The Board would like to thank shareholders for their understanding during this challenging time.

 

Kathryn Hudson

Company Secretary

 

16 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKPBQFBKDAQD
Date   Source Headline
28th Feb 20259:43 amRNSDirector/PDMR Shareholding
28th Feb 20259:42 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20254:31 pmRNSDirector/PDMR Shareholding
27th Feb 20254:29 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSJoseph Ciaffoni Appointed Chief Executive Officer
25th Feb 20257:00 amRNSHolding(s) in Company
24th Feb 20257:00 amRNSFDA Approval of SUBLOCADE Label Changes
20th Feb 20257:00 amRNSFinal Results
12th Feb 20257:00 amRNSDelayed FDA Approval of SUBLOCADE Label Changes
4th Feb 20253:12 pmRNSNotice of Results
4th Feb 20257:00 amRNSCompletion of Share Repurchase Program
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20259:26 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSAppointment of Independent Non-Executive Director
28th Jan 20253:30 pmRNSDr. David Wheadon appointed Chair of the Board
28th Jan 20259:43 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20259:08 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20254:00 pmRNSReplacement Transaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20251:00 pmRNSIndivior Provides Historical Financials in US GAAP
7th Jan 20258:55 amRNSHolding(s) in Company
7th Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20259:31 amRNSTotal Voting Rights
31st Dec 20249:53 amRNSHolding(s) in Company
31st Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 202410:32 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSIndivior Announces Changes to Board of Directors
17th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20249:44 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSIndivior to Participate in Upcoming Investor Event
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20248:48 amRNSHolding(s) in Company
15th Nov 20247:00 amRNSDirector Declaration
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20242:29 pmRNSHolding(s) in Company
8th Nov 20244:50 pmRNSBlock listing Interim Review
8th Nov 20247:00 amRNSIndivior Responds to Letter from Oaktree
5th Nov 20247:00 amRNSIndivior Completes Refinance of Secured Term Loan
5th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 202411:59 amRNSTotal Voting Rights
29th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNS3rd Quarter Results
22nd Oct 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.